Mitochondrial function is related to alterations at brain SPECT in depressed patients

CNS Spectrums

Volumn 13, Issue 9, 2008, Pages 805-814

  Gardner, Ann ^a   Salmaso, Dario ^b   Nardo, Davide ^c   Micucci, Federica ^d   Nobili, Flavio ^e   Sanchez Crespo, Alejandro ^a   Jacobsson, Hans ^a   Larsson, Stig A ^a   Pagani, Marco ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b INSTITUTE OF COGNITIVE SCIENCES AND TECHNOLOGIES   (Italy)

^c FATEBENEFRATELLI HOSPITAL   (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

^e UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM; CITRATE SYNTHASE; CLOMIPRAMINE; FLUOXETINE; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; SERTRALINE;

ADULT; ANALYTICAL PARAMETERS; ARTICLE; BRAIN BLOOD FLOW; BRAIN METABOLISM; CELL METABOLISM; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; DEPRESSION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENZYME ACTIVITY; ENZYME ANALYSIS; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; HUMAN TISSUE; MALE; METABOLIC DISORDER; MUSCLE DISEASE; MUSCLE MITOCHONDRION; PRIORITY JOURNAL; RESPIRATORY CHAIN; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYMPTOM;

EID: 54349111625     PISSN: 10928529     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1092852900013936     Document Type: Article

References (59)

1. Nikolaus S, Larisch R, Beu M, Vosberg H, Müller-Gärtner HW. Diffuse cortical reduction of neuronal activity in unipolar major depression: a retrospective analysis of 337 patients and 321 controls. Nucl Med Commun. 2000;21:1119-1125.
2. Pagani M, Salmaso D, Nardo D, et al. Imaging the neurobiological substrate of atypical depression by SPECT. Eur J Nucl Med Mol Imaging. 2007;34:110-120.
3. Krausz Y, Freedman N, Lester H, et al. Brain SPECT study of common ground between hypothyroidsm and depression. Int J Neuropsychopharmacol. 2007;10:99-106.
4. Fountoulakis KN, Iacovides A, Gerasimou G, et al. The relationship of regional cerebral blood flow with subtypes of major depression. Prog Neuropsychopharmacol Biol Psychiatry. 2004;28:537-546.
5. Boone O, Louzoun Y, Aharon I, et al. Cerebral blood flow in depressed patients: a methodological comparison of statistical parametric mapping and region of interest analyses. Psychiatry Res. 2003;122:49-57.
6. Gardner A, Pagani M, Jacobsson H, et al. Differences in resting state regional cerebral blood flow assessed with 99mTc-HMPAO SPECT and brain atlas matching between depressed patients with and without tinnitus. Nucl Med Commun. 2002;23:429-439.
7. Milo TJ, Kaufman GE, Barnes WE, et al. Changes in regional cerebral blood flow after electroconvulsive therapy for depression. J ECT. 2001;17:15-21.
8. Navarro V, Gastó C, Lomeña F, Mateos JJ, Marcos T. Frontal cerebral perfusion dysfunction in elderly late-onset major depression assessed by 99MTC-HMPAO SPECT. Neuroimage. 2001;14(1 pt 1):202-205.
9. McGuffin P, Katz R, Watkins S, Rutherford J. A hospital-based twin register of the heritability uf DSM-IV unipolar depression. Arch Gen Psychiatry. 1996;53:129-136.
10. Fattal O, Link J, Quinn K, Cohen BH, Franco K. Psychiatric comorbidity in 36 adults with mitochondrial cytopathies. CNS Spectr. 2007;12:429-438.
11. Moore CM, Christensen JD, Lafer B, Fava M, Renshaw PF. Lower levels of nucleoside triphosphate in the basal ganglia of depressed subjects: a phosphorous-31 magnetic resonance spectroscopy study. Am J Psychiatry. 1997;154:116-118.
12. Volz HP, Rzanny R, Riehemann S, et al. 31P magnetic resonance spectroscopy in the frontal lobe of major depressed patients. Eur Arch Psychiatry Clin Neurosci. 1998;248:289-295.
13. Gardner A, Johansson A, Wibom R, et al. Alterations of mitochondrial function and correlatons with peroonality traits in selected major depressive disorder patients. J Affect Disord. 2003;76:55-68.
14. Beasley CL, Pennington K, Behan A, Wait R, Dunn MJ, Cotter D. Proteomic analysis of the anterior cingulate cortex is the major psychiatric disorders: evidence for disease-associated changes. Proteomics. 2006;6:3414-3425.
15. Neirinckx RD, Burke JF, Harrison RC, Forster AM, Andersen AR, Lassen NA. The retention mechanism of technetium-99m-HM-PAO: intracellular reaction with glutathione. J Cereb Blood Flow Metab. 1988;8:S4-S12.
16. Babich JW. Technetium-99m-HMPAO and the role of glutathione: the debate continues J Nucl Med. 1991;32:1681-1683.
17. Filosto M, Tonin P, Vattemi G, Spagnolo M, Rizzuto N, Tomelleri G. Antioxidant agents have a different expression pattern in muscle fibers of patients with mitochondrial diseases. Acta Neuropathol (Berl). 2002;103:215-220.
18. Tanabe K, Masuda K, Hirayama A, Nagase S, Konol I, Kuno S. Effect of spontaneous exercise on antiovidant capacity in rat muscles determined by electron spin resonance. Acta Physiol (Oxf). 2006;186:119-125.
19. Benard G, Faustin B, Passerieux E, et al. Physiological diversity of mitochondrial oxidative phosphorylation. Am J Physiol Cell Physiol. 2006;291:C1172-C1182.
20. Miles L, Wong BL, Dinopoulos A, Morehart PJ, Hofmann IA, Bove KE. Investigation of children for mitochondriopathy confirms need for strict patient selection, improved morphological criteria, and better laboratory methods. Hum Pathol. 2006;37:173-184.
21. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.
22. Birch-Machin MA, Briggs HL, Saborido AA, Bindoff LA, Turnbull DM. An evaluation of the measurement of the activities of complexes I-IV in the respiratory chain of human skeletal muscle mitochondria. Biochem Med Metabol Biol. 1994;51:35-42.
23. Sottocasa GL, Kuylenstierna B, Ernster L, Bergstrand A. An electron-transport system associated with the outer membrane of liver mitochondria. A biochemical and morphological study. J Cell Biol. 1967;32:415-438.
24. Cooperstein SJ, Lazarow A, Kurfess NJ. A microspectrophotometric method for the determination of succinic dehydrogenase. J Biol Chem. 1950;186:129-139.
25. Cooperstein SJ, Lazarow A. A microspectrophotometric method for the determination of cytochrome oxidase. J Biol Chem. 1951; 189:665-670.
26. Alp P, Newsholme E, Zammit V. Activities of citrate synthase and NAD+-linkad and NADP+-linked isocitrate dehydrogenase in muscle from vertebrates and invertebrates. Biochem J. 1976;154:689-700.
27. Chang L-T. A method for attenuation correction in radionuclide computed tomography. IEEE Trans Nucl Sci. 1978;25:638-643.
28. The MNI brain and the Talairach atlas subroutine. Available at: http://imaging.mrc-cbu.cam.ac.uk/imaging/MniTalairach. Accessed December 8, 2005.
29. The MNI brain and the Talairach atlas. Available at: http://ric.uthscsa.edu/projects/talairachdaemon.htm. Accessed December 8, 2005.
30. Friston KJ, Holmes A, Poline JB, Price CJ, Frith CD. Detecting activation in PET and fMRI: levels of inference and power. Neuroimage. 1996;4:223-235.
31. Worsley KJ, Marret S, Neelin P, Evans AC. Searching scale space for activation in PET images. Hum Brain Map. 1996;4:74-90.
32. Fujibayashi Y, Taniuchi H, Waki A, Yokoyama A, Ishii Y, Yonekura Y. Intracellular metabolism of 99mTc-d,l-HMPAO in vitro: a basic approach for understanding the hyperfixation mechanism in damaged brain. Nucl Med Biol. 1998;25:375-378.
33. Steele JD, Currie J, Lawrie SM, Reid I. Prefrontal cortical functional abnormality in major depressive disorder: a stereotactic meta-analysis. J Affect Disord. 2007;101:1-11.
34. Marin-Garcia J, Ananthakrishnan R, Goldenthal MJ. Heart mitochondria response to alcohol is different than brain and liver. Alcohol Clin Exp Res. 1995;19:1463-1466.
35. Cocco T, Sgobbo P, Clemente M, et al. Tissue-specific changes of mitochondrial functions in aged rats: effect of a long-term dietary treatment with N-acetylcysteine. Free Radic Biol Med. 2005;38:796-805.
36. Kasahara T, Kubota M, Miyauchi T, et al. Mice with neuron-specific accumulation of mitochodrial DNA mutations show mood disorder-like phenotypes. Mol Psychiatry. 2006;11:577-593, 523.
37. Ross-Stanton J, Meltzer HY. Skeletal muscle morphology of depressed patients after medication. Muscle Nerve. 1979;2:239-240.
38. Simon GE, VonKorff M, Piccinelli M, Fullerton C, Ormel J. An international study of the relation between somatic symptoms and depression. N Engl J Med. 1999;341:1329-1335.
39. Mathew RJ, Weinman ML, Mirabi M. Physical symptoms of depression. Br J Psychiatry. 1981;139:293-296.
40. Gardner A, Boles RG. Mitochondrial energy depletion in depression with somatization. Psychother Psychosom. 2008;77:127-129.
41. Gardner A, Boles RG. Symptoms of somatization as a rapid screening tool for mitochondrial dysfunction in depression. Biopsychosoc Med. 2008;2:7.
42. Rodriguez MC, MacDonald JR, Mahoney DJ, Parise G, Beal MF, Tarnopolsky MA. Beneficial effects of creatine, CoQ10, and lipoic acid in mitochondrial disorders. Muscle Nerve. 2007;35:235-242.
43. Roitman S, Green T, Osher Y, Karni N, Levine J. Creatine monohydrate in resistant depression: a preliminary study. Bipolar Disord. 2007;9:754-758.
44. DiMauro S, Schon EA. Mitochondrial disorders in the nervous system. Annu Rev Neurosci. 2008;31:91-123.
45. Grünwald F, Zierz S, Broich K, Schumacher S, Bockisch A, Biersack HJ. HMPAO-SPECT imaging resembling Alzheimer-type dementia in mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes (MELAS). J Nucl Med. 1990;31:1740-1742.
46. Grünwald F, Zierz S, Broich K, Dewes W, Böker T, Biersack HJ. Brain SPECT imaging with Tc-99m HMPAO in ophthalmoplegia plus. Clin Nucl Med. 1991;1:20-23.
47. Watanabe Y, Hashikawa K, Moriwaki H, et al. SPECT findings in mitochondrial encephalomyopathy. J Nucl Med. 1998;39:961-964.
48. Peng NJ, Liu RS, Li JY, et al. Increased cerebral blood flow in MELAS shown by Tc-99m HMPAO brain SPECT. Neuroradiology. 2000;42:26-29.
49. Amagasaki K, Shimizu T, Suzuki Y, Kakizawa T. Focal hyperperfusion in a patient with mitochondrial myopathy, encaphalopathy, lactic acidosis, and strokelike episodes. Case report. J Neurosurg. 2001; 94:133-136.
50. Lien LM, Lee HC, Wang KL, Chiu JC, Chiu HC, Wei YH. Involvement of nervous system in maternally inherited diabetes and deafness (MIDD) with the A3243G mutation of mitochondrial DNA. Acta Neurol Scand. 2001;103:159-165.
51. Rodriguez G, Nobili F, Tanganelli P, Regesta G, Ottonello G. Cerebral hyperperfusion antedates by years strokelike episodes in the MELAS syndrome. Stroke. 1996;27:341-342.
52. Nariai T, Ohno K, Ohta Y, Hirakawa K, Ishii K, Senda M. Discordance between cerebral oxygen and glucose metabolism, and hemodynamics in a mitochondrial encephalomyopathy, lactic acidosis, and strokelike episode patient. J Neuroimaging. 2001;11:325-329.
53. Battino M, Bertoli E, Formiggini G, Sassi S, Gorini A, Villa RF, Lenaz G. Structural and functional aspects of the respiratory chain of synaptic and nonsynaptic mitochondria derived from selected brain regions. J Bioenerg Biomembr. 1991;23;345-363.
54. Iizuka T, Sakai F. Pathogenesis of stroke-like episodes in MELAS: analysis of neurovascular cellular mechanisms. Curr Neurovasc Res. 2005;2:29-45.
55. Sparaco M, Bonilla E, diMauro S, Powers JM. Neuropathology of mitochondrial encephalomyopathies due to mitochondrial DNA defects. J Neuropathol Exp Neurol. 1993;52:1-10.
56. Sparaco M, Simonati A, Cavallaro T, et al. MELAS: clinical phenotype and morphological brain abnormalities. Acta Neuropathol (Berl). 2003;106:202-212.
57. Filosto M, Tomelleri G, Tonin P, et al. Neuropathology of mitochondrial diseases. Biosci Rep. 2007;27:23-30.
58. Blass JP. Mitochondria, neurodegenerative diseases, and selective neuronal vulnerability. Ann N Y Acad Sci. 1999;893:434-439.
59. Hargreaves IP Sheena Y, Land JM, Heales SJ. Glutathione deficiency in patients with mitochondrial disease: implications for pathogenesis and treatment. J Inherit Metab Dis. 2005;28:81-88.